IBDEI1M0 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,239,0)
;;=NEPHRITIS INTERSTITIAL^19^26
;;^UTILITY(U,$J,358.4,240,0)
;;=NEPHROTIC SYNDROME^21^26
;;^UTILITY(U,$J,358.4,241,0)
;;=OBSTRUCTIVE UROPATHY^22^26
;;^UTILITY(U,$J,358.4,242,0)
;;=TRANSPLANT^26^26
;;^UTILITY(U,$J,358.4,243,0)
;;=CKD/KIDNEY DISEASE^3^26
;;^UTILITY(U,$J,358.4,244,0)
;;=HEMODIALYSIS-AKI^13^26
;;^UTILITY(U,$J,358.4,245,0)
;;=ACUTE KIDNEY INJURY^1^26
;;^UTILITY(U,$J,358.4,246,0)
;;=GLOMERULAR DISEASE^11^26
;;^UTILITY(U,$J,358.4,247,0)
;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^26
;;^UTILITY(U,$J,358.4,248,0)
;;=NEPHROLITHASIS^20^26
;;^UTILITY(U,$J,358.4,249,0)
;;=POISONING & INTOXICATIONS^24^26
;;^UTILITY(U,$J,358.4,250,0)
;;=DIALYSIS^7^26
;;^UTILITY(U,$J,358.4,251,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^25^26
;;^UTILITY(U,$J,358.4,252,0)
;;=ACUTE RENAL FAILURE^1^27
;;^UTILITY(U,$J,358.4,253,0)
;;=CARDIOVASCULAR^3^27
;;^UTILITY(U,$J,358.4,254,0)
;;=CHRONIC KIDNEY DISEASE^4^27
;;^UTILITY(U,$J,358.4,255,0)
;;=CONTACT/EXPOSURE TO COM D^5^27
;;^UTILITY(U,$J,358.4,256,0)
;;=DERMATOLOGY^6^27
;;^UTILITY(U,$J,358.4,257,0)
;;=DIABETES W/ COMPLICATIONS^7^27
;;^UTILITY(U,$J,358.4,258,0)
;;=DIABETES W/O COMPLICATION^8^27
;;^UTILITY(U,$J,358.4,259,0)
;;=EENT^10^27
;;^UTILITY(U,$J,358.4,260,0)
;;=ENDOCRINE/METABOLIC^11^27
;;^UTILITY(U,$J,358.4,261,0)
;;=GASTROENTEROLOGY^12^27
;;^UTILITY(U,$J,358.4,262,0)
;;=GENITOURINARY^13^27
;;^UTILITY(U,$J,358.4,263,0)
;;=HEMATOLOGY/ONCOLOGY^14^27
;;^UTILITY(U,$J,358.4,264,0)
;;=HISTORY & STATUS POST^15^27
;;^UTILITY(U,$J,358.4,265,0)
;;=INFECTIOUS DISEASE^16^27
;;^UTILITY(U,$J,358.4,266,0)
;;=INFLAMMATORY/INF LUNG DX^17^27
;;^UTILITY(U,$J,358.4,267,0)
;;=INTERSTITIAL DISEASE^18^27
;;^UTILITY(U,$J,358.4,268,0)
;;=MENTAL HEALTH^19^27
;;^UTILITY(U,$J,358.4,269,0)
;;=MUSCULOSKELETAL^20^27
;;^UTILITY(U,$J,358.4,270,0)
;;=NEUROLOGY^21^27
;;^UTILITY(U,$J,358.4,271,0)
;;=OBSTRUCTIVE AIRWAY DISEASE^22^27
;;^UTILITY(U,$J,358.4,272,0)
;;=ORAL CAVITY^23^27
;;^UTILITY(U,$J,358.4,273,0)
;;=OTHER REASONS^24^27
;;^UTILITY(U,$J,358.4,274,0)
;;=PAIN^25^27
;;^UTILITY(U,$J,358.4,275,0)
;;=PERSONAL HISTORY^26^27
;;^UTILITY(U,$J,358.4,276,0)
;;=PLEURAL DISEASE^27^27
;;^UTILITY(U,$J,358.4,277,0)
;;=PNEUMONIA^28^27
;;^UTILITY(U,$J,358.4,278,0)
;;=PULMONARY VASCULAR DISEASE^30^27
;;^UTILITY(U,$J,358.4,279,0)
;;=RESPIRATORY^31^27
;;^UTILITY(U,$J,358.4,280,0)
;;=SECONDARY DIABETES^32^27
;;^UTILITY(U,$J,358.4,281,0)
;;=SIGNS, SYMPTOMS, CONDITIONS^33^27
;;^UTILITY(U,$J,358.4,282,0)
;;=SLEEP DISORDERS^34^27
;;^UTILITY(U,$J,358.4,283,0)
;;=THROMBO EMBOLIC DISEASE^35^27
;;^UTILITY(U,$J,358.4,284,0)
;;=TUMOR^36^27
;;^UTILITY(U,$J,358.4,285,0)
;;=VASCULAR^37^27
;;^UTILITY(U,$J,358.4,286,0)
;;=PRE-OP/POST-OP/COUNSELING^29^27
;;^UTILITY(U,$J,358.4,287,0)
;;=E-CONSULTS^9^27
;;^UTILITY(U,$J,358.4,288,0)
;;=ANTICOAGULATION^2^27
;;^UTILITY(U,$J,358.4,289,0)
;;=E-CONSULT MD/NP/PA^1^28
;;^UTILITY(U,$J,358.4,290,0)
;;=E-CONSULT NON-LIP^2^28
;;^UTILITY(U,$J,358.4,291,0)
;;=NEW PATIENT^2^29
;;^UTILITY(U,$J,358.4,292,0)
;;=ESTABLISHED PATIENT^1^29
;;^UTILITY(U,$J,358.4,293,0)
;;=CONSULTATIONS^3^29
;;^UTILITY(U,$J,358.4,294,0)
;;=ENDOCRINE DX^1^30
;;^UTILITY(U,$J,358.4,295,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^2^30
;;^UTILITY(U,$J,358.4,296,0)
;;=BIOPSIES^1^31
;;^UTILITY(U,$J,358.4,297,0)
;;=INJECTIONS & INFUSIONS^2^31
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1M0 3777 printed Nov 22, 2024@17:21:30 Page 2
IBDEI1M0 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,239,0)
+2 ;;=NEPHRITIS INTERSTITIAL^19^26
+3 ;;^UTILITY(U,$J,358.4,240,0)
+4 ;;=NEPHROTIC SYNDROME^21^26
+5 ;;^UTILITY(U,$J,358.4,241,0)
+6 ;;=OBSTRUCTIVE UROPATHY^22^26
+7 ;;^UTILITY(U,$J,358.4,242,0)
+8 ;;=TRANSPLANT^26^26
+9 ;;^UTILITY(U,$J,358.4,243,0)
+10 ;;=CKD/KIDNEY DISEASE^3^26
+11 ;;^UTILITY(U,$J,358.4,244,0)
+12 ;;=HEMODIALYSIS-AKI^13^26
+13 ;;^UTILITY(U,$J,358.4,245,0)
+14 ;;=ACUTE KIDNEY INJURY^1^26
+15 ;;^UTILITY(U,$J,358.4,246,0)
+16 ;;=GLOMERULAR DISEASE^11^26
+17 ;;^UTILITY(U,$J,358.4,247,0)
+18 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^26
+19 ;;^UTILITY(U,$J,358.4,248,0)
+20 ;;=NEPHROLITHASIS^20^26
+21 ;;^UTILITY(U,$J,358.4,249,0)
+22 ;;=POISONING & INTOXICATIONS^24^26
+23 ;;^UTILITY(U,$J,358.4,250,0)
+24 ;;=DIALYSIS^7^26
+25 ;;^UTILITY(U,$J,358.4,251,0)
+26 ;;=SUICIDE IDEATIONS/ATTEMPTS^25^26
+27 ;;^UTILITY(U,$J,358.4,252,0)
+28 ;;=ACUTE RENAL FAILURE^1^27
+29 ;;^UTILITY(U,$J,358.4,253,0)
+30 ;;=CARDIOVASCULAR^3^27
+31 ;;^UTILITY(U,$J,358.4,254,0)
+32 ;;=CHRONIC KIDNEY DISEASE^4^27
+33 ;;^UTILITY(U,$J,358.4,255,0)
+34 ;;=CONTACT/EXPOSURE TO COM D^5^27
+35 ;;^UTILITY(U,$J,358.4,256,0)
+36 ;;=DERMATOLOGY^6^27
+37 ;;^UTILITY(U,$J,358.4,257,0)
+38 ;;=DIABETES W/ COMPLICATIONS^7^27
+39 ;;^UTILITY(U,$J,358.4,258,0)
+40 ;;=DIABETES W/O COMPLICATION^8^27
+41 ;;^UTILITY(U,$J,358.4,259,0)
+42 ;;=EENT^10^27
+43 ;;^UTILITY(U,$J,358.4,260,0)
+44 ;;=ENDOCRINE/METABOLIC^11^27
+45 ;;^UTILITY(U,$J,358.4,261,0)
+46 ;;=GASTROENTEROLOGY^12^27
+47 ;;^UTILITY(U,$J,358.4,262,0)
+48 ;;=GENITOURINARY^13^27
+49 ;;^UTILITY(U,$J,358.4,263,0)
+50 ;;=HEMATOLOGY/ONCOLOGY^14^27
+51 ;;^UTILITY(U,$J,358.4,264,0)
+52 ;;=HISTORY & STATUS POST^15^27
+53 ;;^UTILITY(U,$J,358.4,265,0)
+54 ;;=INFECTIOUS DISEASE^16^27
+55 ;;^UTILITY(U,$J,358.4,266,0)
+56 ;;=INFLAMMATORY/INF LUNG DX^17^27
+57 ;;^UTILITY(U,$J,358.4,267,0)
+58 ;;=INTERSTITIAL DISEASE^18^27
+59 ;;^UTILITY(U,$J,358.4,268,0)
+60 ;;=MENTAL HEALTH^19^27
+61 ;;^UTILITY(U,$J,358.4,269,0)
+62 ;;=MUSCULOSKELETAL^20^27
+63 ;;^UTILITY(U,$J,358.4,270,0)
+64 ;;=NEUROLOGY^21^27
+65 ;;^UTILITY(U,$J,358.4,271,0)
+66 ;;=OBSTRUCTIVE AIRWAY DISEASE^22^27
+67 ;;^UTILITY(U,$J,358.4,272,0)
+68 ;;=ORAL CAVITY^23^27
+69 ;;^UTILITY(U,$J,358.4,273,0)
+70 ;;=OTHER REASONS^24^27
+71 ;;^UTILITY(U,$J,358.4,274,0)
+72 ;;=PAIN^25^27
+73 ;;^UTILITY(U,$J,358.4,275,0)
+74 ;;=PERSONAL HISTORY^26^27
+75 ;;^UTILITY(U,$J,358.4,276,0)
+76 ;;=PLEURAL DISEASE^27^27
+77 ;;^UTILITY(U,$J,358.4,277,0)
+78 ;;=PNEUMONIA^28^27
+79 ;;^UTILITY(U,$J,358.4,278,0)
+80 ;;=PULMONARY VASCULAR DISEASE^30^27
+81 ;;^UTILITY(U,$J,358.4,279,0)
+82 ;;=RESPIRATORY^31^27
+83 ;;^UTILITY(U,$J,358.4,280,0)
+84 ;;=SECONDARY DIABETES^32^27
+85 ;;^UTILITY(U,$J,358.4,281,0)
+86 ;;=SIGNS, SYMPTOMS, CONDITIONS^33^27
+87 ;;^UTILITY(U,$J,358.4,282,0)
+88 ;;=SLEEP DISORDERS^34^27
+89 ;;^UTILITY(U,$J,358.4,283,0)
+90 ;;=THROMBO EMBOLIC DISEASE^35^27
+91 ;;^UTILITY(U,$J,358.4,284,0)
+92 ;;=TUMOR^36^27
+93 ;;^UTILITY(U,$J,358.4,285,0)
+94 ;;=VASCULAR^37^27
+95 ;;^UTILITY(U,$J,358.4,286,0)
+96 ;;=PRE-OP/POST-OP/COUNSELING^29^27
+97 ;;^UTILITY(U,$J,358.4,287,0)
+98 ;;=E-CONSULTS^9^27
+99 ;;^UTILITY(U,$J,358.4,288,0)
+100 ;;=ANTICOAGULATION^2^27
+101 ;;^UTILITY(U,$J,358.4,289,0)
+102 ;;=E-CONSULT MD/NP/PA^1^28
+103 ;;^UTILITY(U,$J,358.4,290,0)
+104 ;;=E-CONSULT NON-LIP^2^28
+105 ;;^UTILITY(U,$J,358.4,291,0)
+106 ;;=NEW PATIENT^2^29
+107 ;;^UTILITY(U,$J,358.4,292,0)
+108 ;;=ESTABLISHED PATIENT^1^29
+109 ;;^UTILITY(U,$J,358.4,293,0)
+110 ;;=CONSULTATIONS^3^29
+111 ;;^UTILITY(U,$J,358.4,294,0)
+112 ;;=ENDOCRINE DX^1^30
+113 ;;^UTILITY(U,$J,358.4,295,0)
+114 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^30
+115 ;;^UTILITY(U,$J,358.4,296,0)
+116 ;;=BIOPSIES^1^31
+117 ;;^UTILITY(U,$J,358.4,297,0)
+118 ;;=INJECTIONS & INFUSIONS^2^31
